DAPA - Egypt Study

Clinical trial NCT03624803 · COMPLETED

Trial details

NCT number: NCT03624803
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Type-2 Diabetes

Start date: 2019-03-09
Primary completion: 2020-03-30
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.